RDPTF
Radiopharm Theranostics LtdPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Mar 27 Radiopharm Theranostics has dosed the first patient in its Phase 1 c…
- R Apr 7 Radiopharm Theranostics announced a clinical supply agreement with S…
- R Apr 8 Radiopharm Theranostics announced that its Phase 1 'HEAT' clinical t…
- R Apr 16 Radiopharm Theranostics announced completion of patient dosing in it…
Signal stack
Where each data set points today.
- TrendRANGE
16% below its 50-day average. New closing low $0.006660 on Oct 23.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $1.1M |
| Next FY | 🔒 Fresh data, subscribers only | |||
SecBot reports
8 filings · 4 bullish · 0 bearish · 1 mixed · 3 neutral- NEUTRAL 6-KJun 3, 2026
Radiopharm Theranostics filed a Form 6-K reporting the expiry of 505,598 unquoted options (RADAN)…
No trading action warranted. This is a routine ASX Appendix 3H notification of option expiry with immaterial scale. Monitor the company's upcoming quarterly activities and pipeline catalysts for any…
- NEUTRAL 3May 6, 2026
Form 3 initial beneficial ownership filing for Dr. Dimitris Voliotis, newly appointed Chief…
Routine insider filing for a new CMO. No trading signal. Monitor for any subsequent Form 4 filings that would indicate actual share purchases or sales by the officer.
- MIXED 6-KApr 23, 2026
Radiopharm Theranostics reported strong clinical progress across its pipeline, including…
Monitor upcoming data readouts from mid-2026, which could be catalysts, but watch for potential equity financing given the tight cash position.
- BULLISH 6-KApr 16, 2026
Radiopharm Theranostics announced completion of patient dosing in its U.S. Phase 2b trial of RAD…
Review the filing for details
All RDPTF filing & press-release reports (8)
- 6-K reportJun 3, 2026
- 3 reportMay 6, 2026
- 6-K reportApr 23, 2026
- 6-K reportApr 16, 2026
- 6-K reportApr 8, 2026
- 6-K reportApr 7, 2026
- 3 reportApr 1, 2026
- 6-K reportMar 27, 2026